投资工具 / 美股
CVS Health · CVS
数据仅供参考,不构成投资建议。
投资工具 / 美股
数据仅供参考,不构成投资建议。
| 季度 | 截止日 | 申报日 | 营收 | 营收同比 g | Δg | 推导方式 |
|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | 2026-11-04 | $108.4B | +5.4% | −1.9pp | 3M |
| 2026Q2 | 2026-06-30 | 2026-08-05 | $106.1B | +7.3% | +1.1pp | 3M |
| 2026Q1 | 2026-03-31 | 2026-05-06 | $100.43B | +6.2% | −2.0pp | 3M |
| 2025Q4 | 2025-12-31 | 2026-11-04 | $105.69B | +8.2% | +0.4pp | FY-9M |
| 2025Q3 | 2025-09-30 | 2026-11-04 | $102.87B | +7.8% | −0.6pp | 3M |
| 2025Q2 | 2025-06-30 | 2026-08-05 | $98.92B | +8.4% | +1.5pp | 3M |
| 2025Q1 | 2025-03-31 | 2026-05-06 | $94.59B | +7.0% | +2.8pp | 3M |
| 2024Q4 | 2024-12-31 | 2026-02-10 | $97.71B | +4.2% | −2.2pp | FY-9M |
口径:单季同比;Δg = 本季 g − 上季 g;按财季映射日历季度;申报日可见。† 不连续点(上年同季营收 ≤0 或 Δg 幅度超过 50pp)。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 季度 | 截止日 | 毛利 | 销货成本 | 毛利率 | 环比 | 同比 | Δ² |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | 缺口径:GrossProfit 最后申报于 2018-09-30 | $61.19B | 43.6% | −96bp | −99bp | −11bp |
| 2026Q2 | 2026-06-30 | 缺口径:GrossProfit 最后申报于 2018-09-30 | $58.86B | 44.5% | −27bp | −88bp |
| 季度 | 截止日 | 合同负债 | CL g | RPO | RPO g | 账单额 | 账单额 g | RPO 覆盖 |
|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 无数据 | 无数据 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 无数据 |
| 2026Q2 | 2026-06-30 |
| 季度 | 截止日 | OCF TTM | OCF g | CapEx TTM | CapEx g | FCF TTM | CapEx 密度 | SBC/FCF | SBC/Rev |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $18.71B | +105.4% | $3.14B | +11.5% | $15.57B | 0.7% | 4.8% | 0.2% |
| 2026Q2 | 2026-06-30 | $14.78B |
| 交易日 | 申报日 | 申报人 | 头衔 | 代码 | 股数 | 价格 | 金额 | 10b5-1 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-06 | 2026-11-06 | Shah Prem S | EVP and Group President | P | 23,855 | $83.89 | $2M | |
口径:修正广度 =(近 30 日上调 − 下调)/(上调 + 下调),样本 < 3 不出;只展示衍生指标,不展示一致预期原值。 · 数据截至 2026-11-16 · 来源:Yahoo Finance / Nasdaq
未覆盖(期权覆盖为 S&P 500 期权持仓前 100 名每日、其余每周轮换)
暂无警报
口径:本股的警报事件历史(含基线);事件保留 90 天。
该类型不适用:存货
| +35bp |
| 2026Q1 | 2026-03-31 | 缺口径:GrossProfit 最后申报于 2018-09-30 | $55.44B | 44.8% | +67bp | −123bp | −191bp |
| 2025Q4 | 2025-12-31 | 缺口径:GrossProfit 最后申报于 2018-09-30 | $59.06B | 44.1% | −43bp | +68bp | +65bp |
| 2025Q3 | 2025-09-30 | 缺口径:GrossProfit 最后申报于 2018-09-30 | $57.05B | 44.5% | −86bp | +3bp | −17bp |
| 2025Q2 | 2025-06-30 | 缺口径:GrossProfit 最后申报于 2018-09-30 | $54.01B | 45.4% | −62bp | +20bp | −18bp |
| 2025Q1 | 2025-03-31 | 缺口径:GrossProfit 最后申报于 2018-09-30 | $51.06B | 46.0% | +258bp | +38bp | −426bp |
| 2024Q4 | 2024-12-31 | 缺口径:GrossProfit 最后申报于 2018-09-30 | $55.27B | 43.4% | −108bp | +464bp | −80bp |
缺口径:毛利(GrossProfit 最后申报于 2018-09-30)
口径:GM = 毛利/营收;毛利缺失时用 营收−销货成本 推导;环比/同比为基点。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 |
| 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 |
| 无数据 |
| 无数据 |
| 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 |
| 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 |
| 无数据 |
| 2026Q1 | 2026-03-31 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 无数据 | 无数据 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 缺口径:ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31 | 无数据 |
| 2025Q4 | 2025-12-31 | $62M | −56.9% | 无数据 | 无数据 | $105.7B | +8.2% | 无数据 |
| 2025Q3 | 2025-09-30 | $58M | −66.7% | 无数据 | 无数据 | $102.87B | +7.7% | 无数据 |
| 2025Q2 | 2025-06-30 | $61M | −52.3% | 无数据 | 无数据 | $98.91B | +8.4% | 无数据 |
| 2025Q1 | 2025-03-31 | $65M | −44.4% | 无数据 | 无数据 | $94.51B | +6.9% | 无数据 |
| 2024Q4 | 2024-12-31 | $144M | −3.4% | 无数据 | 无数据 | $97.68B | +4.1% | 无数据 |
缺口径:合同负债(ContractWithCustomerLiabilityCurrent 最后申报于 2025-12-31)
口径:g = 同比;账单额 = 营收 + Δ合同负债(同口径);RPO 覆盖 = RPO / TTM 营收。跨口径(总额/仅流动)不比较。 合同负债口径: — · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| +95.3% |
| $3.02B |
| +8.4% |
| $11.76B |
| 0.7% |
| 6.1% |
| 0.2% |
| 2026Q1 | 2026-03-31 | $10.33B | +17.9% | $2.94B | +4.2% | $7.39B | 0.7% | 9.1% | 0.2% |
| 2025Q4 | 2025-12-31 | $10.64B | +16.8% | $2.83B | +1.8% | $7.81B | 0.7% | 6.9% | 0.1% |
| 2025Q3 | 2025-09-30 | $9.11B | +97.5% | $2.82B | −3.7% | $6.29B | 0.7% | 8.5% | 0.1% |
| 2025Q2 | 2025-06-30 | $7.57B | −6.2% | $2.79B | −0.4% | $4.78B | 0.7% | 11.1% | 0.1% |
| 2025Q1 | 2025-03-31 | $8.76B | −19.6% | $2.82B | +2.4% | $5.94B | 0.7% | 8.9% | 0.1% |
| 2024Q4 | 2024-12-31 | $9.11B | −32.2% | $2.78B | −8.2% | $6.33B | 0.7% | 8.5% | 0.1% |
口径:TTM = 近四个离散单季之和;FCF = OCF − CapEx;CapEx 密度 = CapEx/营收 TTM;FCF≤0 时 SBC/FCF 不计算。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 2026-05-21 |
| 2026-05-21 |
| ROBBINS LARRY |
| — |
| S |
| 370,462 |
| $93.45 |
| $34.62M |
| 2026-05-20 | 2026-05-21 | ROBBINS LARRY | — | S | 152,691 | $94.81 | $14.48M |
| 2026-05-20 | 2026-05-21 | ROBBINS LARRY | — | S | 797,628 | $93.48 | $74.56M |
| 2026-05-20 | 2026-05-21 | ROBBINS LARRY | — | S | 800 | $96.28 | $77.02K |
| 2026-05-20 | 2026-05-21 | ROBBINS LARRY | — | S | 66,881 | $95.67 | $6.4M |
| 2026-05-19 | 2026-05-21 | ROBBINS LARRY | — | S | 151 | $95.18 | $14.37K |
| 2026-05-19 | 2026-05-21 | ROBBINS LARRY | — | S | 1,983,387 | $94.45 | $187.33M |
| 2026-05-08 | 2026-05-11 | Mandadi Tilak | EVP, Chief Exp & Tech Officer | S | 69,551 | $89.58 | $6.23M |
| 2025-08-20 | 2025-08-29 | Finucane Anne A. | — | S | 7,500 | $71.02 | $532.65K |
| 2025-06-05 | 2025-06-09 | SANSONE GUY P | — | P | 1,570 | $63.70 | $100.01K |
| 2025-05-06 | 2025-05-06 | ROBBINS LARRY | — | S | 150,000 | $66.67 | $10M |
| 2025-05-05 | 2025-05-06 | ROBBINS LARRY | — | S | 1,226,933 | $67.37 | $82.66M |
| 2025-05-05 | 2025-05-06 | ROBBINS LARRY | — | S | 96,999 | $67.99 | $6.59M |
| 2025-05-02 | 2025-05-06 | ROBBINS LARRY | — | S | 373,776 | $69.66 | $26.04M |
| 2025-05-02 | 2025-05-06 | ROBBINS LARRY | — | S | 1,679,736 | $67.39 | $113.2M |
| 2025-05-02 | 2025-05-06 | ROBBINS LARRY | — | S | 222,556 | $68.38 | $15.22M |
| 2025-03-05 | 2025-03-07 | Clark James David | SVP, Cont & Chief Acct Officer | S | 7,513 | $66.35 | $498.49K |
| 2025-02-18 | 2025-02-19 | Mahoney Michael F | — | P | 30,000 | $66.70 | $2M |
| 2025-01-23 | 2026-01-27 | Nelson Steven H | EVP and President, Aetna | P | 24 | $53.70 | $1.29K |
| 2024-10-23 | 2025-10-14 | CAPOZZI HEIDI B | EVP and Chief People Officer | P | 35 | $56.85 | $1.99K |
| 2024-10-02 | 2025-10-14 | CAPOZZI HEIDI B | EVP and Chief People Officer | P | 10 | $62.24 | $622.4 |
| 2024-09-09 | 2025-10-14 | CAPOZZI HEIDI B | EVP and Chief People Officer | P | 35 | $56.47 | $1.98K |
口径:Form 4/4A 公开市场买入(P)与卖出(S),申报人为董事或高管;汇总与集群为近 365 天,明细为最近 40 笔。 · 数据截至 2026-11-16 · 来源:SEC EDGAR Form 4
口径:SI 来自 FINRA(双周结算);SI% 分母 = SEC 封面总股本;借券费为 IBKR 报价(非全市场);卖空占比 = 当日卖空量/总成交量。 · 数据截至 SI 2026-10-30 · Reg SHO 2026-11-16 · 借券 2026-11-11 · 沿用上一版 · 来源:FINRA、IBKR、iBorrowDesk